Nov 29, 2001 (CIDRAP News) The US Department of Health and Human Services (HHS) has awarded Acambis Inc. a $428 million contract to produce an additional 155 million doses of smallpox vaccine by the end of 2002, HHS Secretary Tommy G. Thompson announced Wednesday.
(CIDRAP News) The US Department of Health and Human Services (HHS) will soon release about 20% of the $1 billion in bioterrorism preparedness funding that is slated to go to states this year, HHS Secretary Tommy G. Thompson announced Jan 25.
(CIDRAP News) In view of the specter of bioterrorism, it's time to overhaul the hodgepodge of outdated, little-known, inconsistent state laws dealing with public health emergencies in the United States, an expert on the subject told a conference audience in Minneapolis yesterday.
(CIDRAP News) The proposed 2003 budget for the US Department of Health and Human Services (HHS) features a 45% increase in spending for bioterrorism preparedness, with research at the National Institutes of Health (NIH) accounting for much of the increase.
(CIDRAP News) The US House and Senate this week approved legislation providing for a wide range of bioterrorism preparedness measures, from funds for hospital preparedness to tracking of dangerous pathogens and increased inspections of imported food.
(CIDRAP News) The United States' food supply makes an attractive target for terrorists, and people in the food industry need to talk more frankly about the risks, bioterrorism expert Michael T. Osterholm, PhD, MPH, said in a Minneapolis speech yesterday.
(CIDRAP News) Ð The smallpox vaccine being produced by Acambis plc for the US government as part of the nation's bioterrorism preparedness program worked well in a Phase I trial, Acambis officials announced this week.
The vaccine, called ACAM1000, generated a characteristic skin lesion or "take" in all those vaccinated, and there were no serious or unusual side effects, the company reported in a Sep 3 news release.
(CIDRAP News) The Food and Drug Administration (FDA) has updated the licensing for the government's decades-old stockpile of Dryvax smallpox vaccine by approving a new vaccine kit that includes a new diluent and bifurcated needles, according to federal officials.
(CIDRAP News) Now that the federal government has some licensed smallpox vaccine in its stockpile, a presidential announcement on vaccination recommendations may be coming very soon, bioterrorism expert Michael T. Osterholm, PhD, MPH, predicted last week.
"I believe that in the next days you'll be hearing from the president about this vaccine," Osterholm told healthcare workers at a meeting in Minneapolis.